Patents Assigned to Hugel, Inc.
  • Patent number: 11169144
    Abstract: A new cell line and an antibody for determining the activity of botulinum toxin are disclosed. Also disclosed is a method of determining the activity of botulinum toxin using the cell line and/or the antibody.
    Type: Grant
    Filed: May 12, 2020
    Date of Patent: November 9, 2021
    Assignee: HUGEL, INC.
    Inventors: Chee Gun Lee, Ji Hyun Oum, Vijayakumar Ajay, Xiangai Gui
  • Publication number: 20210063383
    Abstract: A new cell line and an antibody for determining the activity of botulinum toxin are disclosed. Also disclosed is a method of determining the activity of botulinum toxin using the cell line and/or the antibody.
    Type: Application
    Filed: September 23, 2020
    Publication date: March 4, 2021
    Applicant: HUGEL, INC.
    Inventors: Chee Gun LEE, Ji Hyun OUM, Vijayakumar AJAY, Xiangai GUI
  • Patent number: 10908148
    Abstract: A new cell line and an antibody for determining the activity of botulinum toxin are disclosed. Also disclosed is a method of determining the activity of botulinum toxin using the cell line and/or the antibody.
    Type: Grant
    Filed: May 12, 2020
    Date of Patent: February 2, 2021
    Assignee: HUGEL, INC.
    Inventors: Chee Gun Lee, Ji Hyun Oum, Vijayakumar Ajay, Xiangai Gui
  • Patent number: 10866232
    Abstract: Anew cell line and an antibody for determining the activity of botulinum toxin are disclosed. Also disclosed is a method of determining the activity of botulinum toxin using the cell line and/or the antibody.
    Type: Grant
    Filed: May 12, 2020
    Date of Patent: December 15, 2020
    Assignee: HUGEL, INC.
    Inventors: Chee Gun Lee, Ji Hyun Oum, Vijayakumar Ajay, Xiangai Gui
  • Patent number: 10823725
    Abstract: The present invention relates to a cell and an antibody for determining the activity of botulinum toxin, and a method of determining the activity of botulinum toxin using the same.
    Type: Grant
    Filed: January 11, 2019
    Date of Patent: November 3, 2020
    Assignee: HUGEL, INC.
    Inventors: Chee Gun Lee, Ji Hyun Oum, Vijayakumar Ajay, Xiangai Gui
  • Patent number: 10525111
    Abstract: The present invention relates to microstructure formulation techniques for botulinum toxin. The microstructure formulation techniques for botulinum toxin according to the present invention make it possible to precisely control the concentration of botulinum toxin and to alleviate the pain occurring when botulinum toxin is administered into the human body, and also enable botulinum toxin to be accurately administered to a desired position. Thus, the present invention is expected to greatly contribute to the safe and convenient medical use of botulinum toxin.
    Type: Grant
    Filed: October 12, 2017
    Date of Patent: January 7, 2020
    Assignees: Hugel, Inc., Small Lab Co., Ltd.
    Inventors: Kyeong Yeop Moon, Chang Jin Lee, Dae Gun Kim, Dong Hoon Oh, Do Hyun Kang, Woo Ran Lee, Jeong Gyu Lee, Jun Jin Yoon